Listing 1 - 10 of 12 << page
of 2
>>
Sort by

Book
Purchasing power parities and real expenditures./parites de pouvoir d'achat et depenses reelles 1985.
Author:
ISBN: 9264030182 9789264030183 Year: 1987 Publisher: Paris Ocde/Oecd

Growth of government in the west.
Author:
ISBN: 0844732850 Year: 1978 Publisher: Washington D.C. American Enterprise Institute For Public Policy Research


Book
Les comptes économiques de l'UE 1996.
Authors: ---
ISBN: 9282818780 9789282818787 Year: 1997 Publisher: Luxembourg : Office des publications officielles des communautés européennes = Office for official publications of the European communities = OPOCE,


Book
Parités de pouvoir d'achat et dépenses réelles dans les pays de l'OCDE
Author:
ISBN: 9264227644 9264235094 9264227636 9789264227644 Year: 1985 Publisher: Paris OCDE

Loading...
Export citation

Choose an application

Bookmark

Abstract

This review assesses the performance of Colombian agriculture over the last two decades, evaluates Colombian agricultural policy reforms and provides recommendations to address key challenges in the future. The evaluation is based on the approach that agriculture policy should be evidence-based and carefully designed and implemented to support productivity, competitiveness and sustainability, while avoiding unnecessary distortions to production decisions and to trade. The report includes a special chapter focusing on agricultural innovation.


Multi
Au-delà du PIB : pour une autre mesure de la richesse
Author:
ISSN: 19580657 ISBN: 9782081216518 2081216515 Year: 2008 Volume: 796 Publisher: Paris : Flammarion,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Au début de l'année 2008, alors que les revendications relatives au pouvoir d'achat s'intensifiaient, le président de la République, Nicolas Sarkozy, déclara que l'indice du PIB (Produit intérieur brut) était inapte à représenter les évolutions économiques et sociales, et qu'il était urgent d'élaborer d'autres indicateurs de croissance. À cette fin, il chargea deux prix Nobel d'économie Amartya Sen et Joseph Stiglitz, de constituer une commission. La réflexion sur les limites de PIB comme critère de mesure du bien-être ne date pourtant pas d'hier. Voilà déjà trente ans outre-Atlantique, puis plus précisément depuis les années 1990, que le débat est lancé. En France, la sociologue Dominique Méda en a fait l'un des axes fondateurs de ses travaux. Dès 1999, dans Qu'est-ce que la richesse ? Elle remarquait que le PIB n'est affecté ni par la montée de la violence, ni par le développement des inégalités ou l'altération de l'environnement - et, inversement, n'est pas valorisé en cas d'accroissement constant du niveau d'éducation ou d'amélioration de l'état de santé de la population. Et de conclure : " Si ce qui importe, c'est ce qui est productif ; comment donner de la valeur à des activités qui ne sont productives de rien, seulement de relation, de sens, de qualité de vie ? ". À l'heure où le mot d'ordre du gouvernement en place est " Travailler plus pour gagner plus ", cette réflexion, on s'en doute, revêt une acuité toute particulière...

Keywords

Économie politique --- Sociologie économique --- Produit intérieur brut --- Utilité (économie politique) --- Bien-être --- Aspect moral --- BPB0906 --- Indicateur économique --- AA / International- internationaal --- 339.10 --- 313 --- Bruto binnenlands product --- Economische indicator --- Raming van het goederenbezit en van het inkomen: algemeenheden. --- Levenswijze en levensstandaard. Levensminimum. sociale indicatoren (Studiën). --- Sociologie économique. --- Produit intérieur brut. --- Bien-être. --- Aspect moral. --- majandusnäitaja --- ekonominis rodiklis --- economische indicator --- indicatore economico --- táscaire eacnamaíoch --- indicador económico --- indicator economic --- економски показател --- икономически индикатор --- hospodársky ukazovateľ --- gospodarski kazalec --- ekonomikas rādītājs --- економски показатељ --- ekonomski pokazatelj --- hospodářský ukazatel --- gazdasági mutató --- οικονομικός δείκτης --- wskaźnik gospodarczy --- økonomisk indikator --- tregues ekonomik --- Wirtschaftsindikator --- economic indicator --- indikatur ekonomiku --- ekonomisk indikator --- taloudellinen indikaattori --- ekonomický ukazatel --- економски индикатор --- indice economico --- бруто домашен производ --- bruttokansantuote --- iekšzemes kopprodukts --- olltáirgeacht intíre --- bruto domaći proizvod --- produto interno bruto --- bendrasis vidaus produktas --- hrubý domácí produkt --- Bruttoinlandsprodukt --- hrubý domáci produkt --- producto interior bruto --- брутен вътрешен продукт --- bruto domači proizvod --- bruto binnenlands product --- prodotto interno lordo --- produs intern brut --- ακαθάριστο εγχώριο προϊόν --- sisemajanduse kogutoodang --- bruttó hazai termék --- produkti i brendshëm bruto --- produkt krajowy brutto --- бруто домаћи производ --- bruttonationalprodukt --- gross domestic product --- prodott domestiku gross --- pib --- BDP --- BBP --- PBB --- HDP --- BVP --- PIB --- ΑΕγχΠ --- PIL --- BNP --- БДП --- BIP --- bruto binnenlands produkt --- GDP --- BKT --- SKT --- IKP --- Raming van het goederenbezit en van het inkomen: algemeenheden --- Levenswijze en levensstandaard. Levensminimum. sociale indicatoren (Studiën) --- Indicateur économique --- Produit intérieur brut


Book
Radiolabeled Compounds for Diagnosis and Treatment of Cancer
Author:
Year: 2021 Publisher: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

Radiopharmaceuticals are used in the diagnosis and treatment of various diseases, especially cancer. In general, radiopharmaceuticals are either salts of radionuclides or radionuclides bound to biologically active molecules, drugs, or cells. Tremendous progress has been made in discovering, developing, and commercializing numerous radiopharmaceuticals for the imaging and therapy of cancer. Significant research is ongoing in academia and the pharmaceutical industry to develop more novel radiolabeled compounds as potential radiopharmaceuticals for unmet needs. This Special Issue aims to focus on all aspects of the design, characterization, evaluation, and development of novel radiolabeled compounds for the diagnosis and treatment of cancer and the application of new radiochemistry and methodologies for the development of novel radiolabeled compounds. Outstanding contributions presented in this Special Issue will significantly add to the field of radiopharmaceuticals.

Keywords

Research & information: general --- Chemistry --- positron emission tomography (PET) --- pyrazoles --- fluorine-18 --- radionuclides --- PET probes --- imaging pharmaceuticals --- hypopharyngeal cancer --- 188Re-liposome --- repeated therapy --- NGS --- microRNA --- aprepitant --- radiopharmaceuticals --- neurokinin 1 receptor antagonist --- radionuclide chelators --- kidney uptake --- cleavable linkers --- neutral endopeptidase (NEP) --- renal brush border enzymes --- prostate-specific membrane antigen (PSMA) --- cancer imaging and therapy --- somatostatin analogs --- radiolabeling --- radionuclide therapy --- imaging --- adrenergic receptor --- positron emission tomography --- radiotracer --- cholecystokinin-2 receptor --- minigastrin --- molecular imaging --- targeted radiotherapy --- lutetium-177 --- EpCAM --- radionuclide --- SPECT --- iodine --- PIB --- breast --- cancer --- PET --- target-specific biomolecules --- immunoPET imaging pharmaceuticals --- production processes --- 124I-labeled monoclonal antibodies --- radiotracers --- AAZTA --- scandium-44 --- FAP --- SA --- DPP --- PREP --- radioiodine labeling --- radioiodination --- biomolecules --- peptides --- proteins --- monoclonal antibodies --- 123,124,125,131I-labeled molecules and biomolecules --- positron emission tomography (PET) --- pyrazoles --- fluorine-18 --- radionuclides --- PET probes --- imaging pharmaceuticals --- hypopharyngeal cancer --- 188Re-liposome --- repeated therapy --- NGS --- microRNA --- aprepitant --- radiopharmaceuticals --- neurokinin 1 receptor antagonist --- radionuclide chelators --- kidney uptake --- cleavable linkers --- neutral endopeptidase (NEP) --- renal brush border enzymes --- prostate-specific membrane antigen (PSMA) --- cancer imaging and therapy --- somatostatin analogs --- radiolabeling --- radionuclide therapy --- imaging --- adrenergic receptor --- positron emission tomography --- radiotracer --- cholecystokinin-2 receptor --- minigastrin --- molecular imaging --- targeted radiotherapy --- lutetium-177 --- EpCAM --- radionuclide --- SPECT --- iodine --- PIB --- breast --- cancer --- PET --- target-specific biomolecules --- immunoPET imaging pharmaceuticals --- production processes --- 124I-labeled monoclonal antibodies --- radiotracers --- AAZTA --- scandium-44 --- FAP --- SA --- DPP --- PREP --- radioiodine labeling --- radioiodination --- biomolecules --- peptides --- proteins --- monoclonal antibodies --- 123,124,125,131I-labeled molecules and biomolecules


Book
Purchasing power parities and real expenditures. Gk results, volume 2/resultats gk. parites de pouvoir d'achat et depenses reelles 1993.
Author:
ISBN: 9264044914 9264047611 Year: 1996 Publisher: Paris Ocde


Book
Radiolabeled Compounds for Diagnosis and Treatment of Cancer
Author:
Year: 2021 Publisher: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

Radiopharmaceuticals are used in the diagnosis and treatment of various diseases, especially cancer. In general, radiopharmaceuticals are either salts of radionuclides or radionuclides bound to biologically active molecules, drugs, or cells. Tremendous progress has been made in discovering, developing, and commercializing numerous radiopharmaceuticals for the imaging and therapy of cancer. Significant research is ongoing in academia and the pharmaceutical industry to develop more novel radiolabeled compounds as potential radiopharmaceuticals for unmet needs. This Special Issue aims to focus on all aspects of the design, characterization, evaluation, and development of novel radiolabeled compounds for the diagnosis and treatment of cancer and the application of new radiochemistry and methodologies for the development of novel radiolabeled compounds. Outstanding contributions presented in this Special Issue will significantly add to the field of radiopharmaceuticals.


Book
Radiolabeled Compounds for Diagnosis and Treatment of Cancer
Author:
Year: 2021 Publisher: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute

Loading...
Export citation

Choose an application

Bookmark

Abstract

Radiopharmaceuticals are used in the diagnosis and treatment of various diseases, especially cancer. In general, radiopharmaceuticals are either salts of radionuclides or radionuclides bound to biologically active molecules, drugs, or cells. Tremendous progress has been made in discovering, developing, and commercializing numerous radiopharmaceuticals for the imaging and therapy of cancer. Significant research is ongoing in academia and the pharmaceutical industry to develop more novel radiolabeled compounds as potential radiopharmaceuticals for unmet needs. This Special Issue aims to focus on all aspects of the design, characterization, evaluation, and development of novel radiolabeled compounds for the diagnosis and treatment of cancer and the application of new radiochemistry and methodologies for the development of novel radiolabeled compounds. Outstanding contributions presented in this Special Issue will significantly add to the field of radiopharmaceuticals.


Book
La réforme des marchés publics
Authors: ---
ISBN: 9782802744252 2802744259 Year: 2014 Volume: 11 Publisher: Bruylant

Loading...
Export citation

Choose an application

Bookmark

Abstract

La commande publique représente, dans la plupart des États membres de l’Union européenne, un pourcentage non négligeable du PIB. À fortiori est-ce le cas en Belgique, où le recours, par les pouvoirs publics, à des entreprises privées en vue d’opérations immobilières, d’achats de fournitures ou de prestations de services est très courant ? Fidèle à une tradition qui l’avait conduite à organiser dans le passé des journées d’études relatives aux grandes législations adoptées en la matière, la Commission Royale Droit et Vie des Affaires a dès lors décidé de consacrer son dernier colloque à la réforme des marchés publics et à sa récente entrée en vigueur. Les travaux se divisent en deux parties : - les problématiques générales : champ d’application, passation, exécution, contrôle juridictionnel sont abordées jusque dans leurs aspects les plus délicats ; - les questions ponctuelles les plus débattues : centrales d’achats et de marchés, dialogue compétitif, promotion immobilière publique, concession de travaux publics, rôle du droit civil dans le régime juridique des marchés publics sont traitées. Les meilleurs spécialistes de la matière, à la fois académiques reconnus et praticiens respectés, ont accepté de prêter leur concours à cette analyse en profondeur de la nouvelle réglementation

Keywords

Public law. Constitutional law --- aanbestedingen --- Belgium --- Juridische aspecten : Overheidsopdrachten --- Aspects juridiques : Marchés publics --- E-books --- produto interno bruto --- Belgique --- marché public --- STRADALEX --- σύναψη δημόσιων συμβάσεων --- verejné obstarávanie --- viešieji pirkimai --- zadávání veřejných zakázek --- avalik hange --- javno naročanje --- overheidsopdrachten --- akkwist pubbliku --- közbeszerzés --- Vergabe öffentlicher Aufträge --- contratação pública --- soláthar poiblí --- offentlig upphandling --- contratación pública --- appalto pubblico --- public procurement --- achiziții publice --- обществени поръчки --- Јавни набавки --- javna nabava --- udzielanie zamówień publicznych --- publiskais iepirkums --- offentligt udbud --- julkinen hankinta --- javna naročila --- offentlige indkøb --- Bélgica --- Belgija --- Belgien --- Belgie --- Belgicko --- België --- Beļģija --- Белгија --- Belgio --- Белгия --- Belgia --- il-Belġju --- An Bheilg --- Βέλγιο --- Belgjika --- Belgia Kuningriik --- Beļģijas Karaliste --- Royaume de Belgique --- Belgian kuningaskunta --- Belgické kráľovstvo --- Koninkrijk België --- Belgijos Karalystė --- das Königreich Belgien --- Βασίλειο του Βελγίου --- Kingdom of Belgium --- Кралство Белгија --- Краљевина Белгија --- Belgické království --- Reino de Bélgica --- ir-Renju tal-Belġju --- Regatul Belgiei --- Kongeriget Belgien --- Кралство Белгия --- Mbretëria e Belgjikës --- Belga Királyság --- Królestwo Belgii --- Konungariket Belgien --- Reino da Bélgica --- Kraljevina Belgija --- Regno del Belgio --- бруто домашен производ --- bruttokansantuote --- iekšzemes kopprodukts --- olltáirgeacht intíre --- bruto domaći proizvod --- bendrasis vidaus produktas --- produit intérieur brut --- hrubý domácí produkt --- Bruttoinlandsprodukt --- hrubý domáci produkt --- producto interior bruto --- брутен вътрешен продукт --- bruto domači proizvod --- bruto binnenlands product --- prodotto interno lordo --- produs intern brut --- ακαθάριστο εγχώριο προϊόν --- sisemajanduse kogutoodang --- bruttó hazai termék --- produkti i brendshëm bruto --- produkt krajowy brutto --- бруто домаћи производ --- bruttonationalprodukt --- gross domestic product --- prodott domestiku gross --- pib --- BDP --- BBP --- PBB --- HDP --- BVP --- PIB --- ΑΕγχΠ --- PIL --- BNP --- БДП --- BIP --- bruto binnenlands produkt --- GDP --- BKT --- SKT --- IKP --- BPB2011 --- Marchés publics Overheidsopdrachten --- Marchés publics --- Droit --- Réforme --- Government purchasing --- Law and legislation --- Congresses --- Marchés publics --- EPUB-ALPHA-R EPUB-LIV-FT LIVDROIT STRADA-B --- marché public

Listing 1 - 10 of 12 << page
of 2
>>
Sort by